Ft Options buys $2,150,443 stake in Alere Inc (ALR)

Alere Inc (ALR) : Ft Options scooped up 17,000 additional shares in Alere Inc during the most recent quarter end , the firm said in a disclosure report filed with the SEC on Aug 12, 2016. The investment management firm now holds a total of 53,163 shares of Alere Inc which is valued at $2,150,443.Alere Inc makes up approximately 2.61% of Ft Options’s portfolio.

Other Hedge Funds, Including , Raymond James Financial Services Advisors sold out all of its stake in ALR during the most recent quarter. The investment firm sold 5,184 shares of ALR which is valued $209,693.Rhumbline Advisers reduced its stake in ALR by selling 881 shares or 1.16% in the most recent quarter. The Hedge Fund company now holds 74,864 shares of ALR which is valued at $3,028,249. Alere Inc makes up approx 0.01% of Rhumbline Advisers’s portfolio.Alliancebernstein boosted its stake in ALR in the latest quarter, The investment management firm added 7,050 additional shares and now holds a total of 55,858 shares of Alere Inc which is valued at $2,259,456.Credit Agricole S A boosted its stake in ALR in the latest quarter, The investment management firm added 12,927 additional shares and now holds a total of 92,903 shares of Alere Inc which is valued at $3,757,926. Alere Inc makes up approx 0.01% of Credit Agricole S A’s portfolio.Gabelli Funds boosted its stake in ALR in the latest quarter, The investment management firm added 68,036 additional shares and now holds a total of 1,425,636 shares of Alere Inc which is valued at $53,404,325. Alere Inc makes up approx 0.32% of Gabelli Funds’s portfolio.

Alere Inc closed down -0.2 points or -0.51% at $39.35 with 4,45,844 shares getting traded on Monday. Post opening the session at $39.55, the shares hit an intraday low of $39.26 and an intraday high of $39.68 and the price fluctuated in this range throughout the day.Shares ended Monday session in Red.

On the company’s financial health, Alere Inc reported $-0.18 EPS for the quarter, missing the analyst consensus estimate by $ -0.73 based on the information available during the earnings call on Aug 17, 2016. Analyst had a consensus of $0.55. The company had revenue of $578.21 million for the quarter, compared to analysts expectations of $588.55 million. The company’s revenue was down -5.7 % compared to the same quarter last year.During the same quarter in the previous year, the company posted $2.43 EPS.

Alere Inc. is a provider of health information through diagnostic tests. The Company operates through professional diagnostics patient self-testing consumer diagnostics and corporate and other segments. The professional diagnostics segment includes an array of diagnostic test products and other in vitro diagnostic tests marketed to medical professionals and laboratories for detection of diseases and conditions within its areas of focus. The patient-self testing segment provides services designed to provide physicians with actionable data that allow them to make decisions in real time deliver care and put the individuals they treat on a pathway to better health. The consumer diagnostics segment consists primarily of manufacturing operations related to its role as the exclusive manufacturer of products for SPD Swiss Precision Diagnostics (SPD) its 50/50 joint venture with The Procter & Gamble Company (P&G).

Comments (0)

Leave a Reply

Your email address will not be published. Required fields are marked *